Applications for our technology
Predictive biocatalysis for APIs
More sophisticated molecules require more sophisticated manufacturing
Compounding complexity in drug manufacturing
As the demand for more complex molecules continues to rise, process development teams face the challenge of unlocking unattainable reactions, streamlining synthesis steps, and promoting sustainable manufacturing.
14
average number of steps required to synthesise a small molecule API in 2021
Almost doubled
number of steps required in last 20 years
>66%
increase in chiral centres in last 20 years
As your in silico partner
Basecamp Research expands your biocatalysis capabilities
Expand your toolbox
Unlock complex transformations by learn from nature
Access novel chemistries in rare enzyme classes
Secure novel IP without regulatory burden for Nagoya compliance
Process-ready enzymes
Computationally match enzymes to your process conditions
Validate and optimise substrate specificity before laboratory testing
Avoid labour-intensive evolution and high-throughput screening
Leapfrog engineering
Achieve a performant enzyme in weeks, not years
Align your R&D investment with your in-house strengths
Outsource efficiently at any stage, from cloning to scale-up
Make the most of your limited time and resources
From trial-and-error to in silico predictions
Our context-led discovery & design approach
Map the protein universe
No prior mechanistic insight required to leverage our map of enzymatic reactions — complete with genomic, chemical, and environmental context
Match to your reaction
Prioritise the best enzymes for your desired reaction before lab testing, aided by our high-throughput, physics-based in silico validation
Refine for scale-up
Enzymes designed to be process-ready from round 1, as our AI is informed by real-world contextual data
Beyond abundance
Superior starting points for enzyme design
65x more
Imine reductases
Imine reductases
26x more
Methyltranferases
Methyltranferases
25x more
Ketoreductases
Ketoreductases
Our superior abundance in diverse biocatalysts over UniProt and other public databases ensures the broadest possible pool to address even the most challenging substrates and reactions
Through our biodiscovery process, we help our partners draw on vastly more natural starting points to design process-ready enzymes for your desired reaction conditions.
Partner with us to develop and license our novel enzymes.
Learn more
Through our biodiscovery process, we help our partners draw on vastly more natural starting points to design process-ready enzymes for your desired reaction conditions.
Partner with us to develop and license our novel enzymes.
Partner with us
See how we can help with your target enzymes and applications
We partner with people all across the bioeconomy, including agritech, food, API manufacture, cosmetics & more.
So whether you're a synthetic biologist developing living therapeutics, a metabolic engineer enhancing biofuel production, or an enzymologist designing biocatalysts for bioplastics, give us a shout!
So whether you're a synthetic biologist developing living therapeutics, a metabolic engineer enhancing biofuel production, or an enzymologist designing biocatalysts for bioplastics, give us a shout!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Rooted in Access and Benefit Sharing
Future-proofed data collection
At the heart of our biodiscovery process is a our commitment to Access and Benefit Sharing (ABS). ABS is a cornerstone principle of the Convention on Biological Diversity and its Nagoya Protocol, which seeks to ensure fair and equitable sharing of benefits arising from the utilisation of genetic resources.
We're building a robust model for long term biodiversity protection through our global sampling partnerships. Each of our samples is collected in compliance with the Nagoya Protocol and with pre-negotiated permission to commercialise with our industry partners. Our aim is to create a world where industrial innovation protects, supports and revitalises our natural biodiversity.
We're building a robust model for long term biodiversity protection through our global sampling partnerships. Each of our samples is collected in compliance with the Nagoya Protocol and with pre-negotiated permission to commercialise with our industry partners. Our aim is to create a world where industrial innovation protects, supports and revitalises our natural biodiversity.